Toll Free: 1-888-928-9744
Published: Mar, 2017 | Pages:
101 | Publisher: QYResearch
Industry: ICT | Report Format: Electronic (PDF)
This report studies the global Nanomedicine market, analyzes and researches the Nanomedicine development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GE Healthcare Johnson & Johnson Mallinckrodt plc Merck & Co. Inc. Nanosphere Inc. Pfizer Inc. Sigma-Tau Pharmaceuticals Inc. Smith & Nephew PLC Stryker Corp Teva Pharmaceutical Industries Ltd. UCB (Union chimique belge) S.A Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Nanomedicine can be split into Regenerative Medicine In-vitro & In-vivo Diagnostics Vaccines Drug Delivery Market segment by Application, Nanomedicine can be split into Clinical Cardiology Urology Genetics Orthopedics Ophthalmology
Table of Contents Global Nanomedicine Market Size, Status and Forecast 2022 1 Industry Overview of Nanomedicine 1.1 Nanomedicine Market Overview 1.1.1 Nanomedicine Product Scope 1.1.2 Market Status and Outlook 1.2 Global Nanomedicine Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Nanomedicine Market by Type 1.3.1 Regenerative Medicine 1.3.2 In-vitro & In-vivo Diagnostics 1.3.3 Vaccines 1.3.4 Drug Delivery 1.4 Nanomedicine Market by End Users/Application 1.4.1 Clinical Cardiology 1.4.2 Urology 1.4.3 Genetics 1.4.4 Orthopedics 1.4.5 Ophthalmology 2 Global Nanomedicine Competition Analysis by Players 2.1 Nanomedicine Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 GE Healthcare 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Nanomedicine Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 Johnson & Johnson 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Nanomedicine Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Mallinckrodt plc 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Nanomedicine Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Merck & Co. Inc. 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Nanomedicine Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Nanosphere Inc. 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Nanomedicine Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Pfizer Inc. 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Nanomedicine Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Sigma-Tau Pharmaceuticals Inc. 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Nanomedicine Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Smith & Nephew PLC 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Nanomedicine Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Stryker Corp 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Nanomedicine Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Teva Pharmaceutical Industries Ltd. 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Nanomedicine Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 UCB (Union chimique belge) S.A 4 Global Nanomedicine Market Size by Type and Application (2012-2017) 4.1 Global Nanomedicine Market Size by Type (2012-2017) 4.2 Global Nanomedicine Market Size by Application (2012-2017) 4.3 Potential Application of Nanomedicine in Future 4.4 Top Consumer/End Users of Nanomedicine 5 United States Nanomedicine Development Status and Outlook 5.1 United States Nanomedicine Market Size (2012-2017) 5.2 United States Nanomedicine Market Size and Market Share by Players (2016 and 2017) 6 EU Nanomedicine Development Status and Outlook 6.1 EU Nanomedicine Market Size (2012-2017) 6.2 EU Nanomedicine Market Size and Market Share by Players (2016 and 2017) 7 Japan Nanomedicine Development Status and Outlook 7.1 Japan Nanomedicine Market Size (2012-2017) 7.2 Japan Nanomedicine Market Size and Market Share by Players (2016 and 2017) 8 China Nanomedicine Development Status and Outlook 8.1 China Nanomedicine Market Size (2012-2017) 8.2 China Nanomedicine Market Size and Market Share by Players (2016 and 2017) 9 India Nanomedicine Development Status and Outlook 9.1 India Nanomedicine Market Size (2012-2017) 9.2 India Nanomedicine Market Size and Market Share by Players (2016 and 2017) 10 Southeast Asia Nanomedicine Development Status and Outlook 10.1 Southeast Asia Nanomedicine Market Size (2012-2017) 10.2 Southeast Asia Nanomedicine Market Size and Market Share by Players (2016 and 2017) 11 Market Forecast by Regions, Type and Application (2017-2022) 11.1 Global Nanomedicine Market Size (Value) by Regions (2017-2022) 11.1.1 United States Nanomedicine Revenue and Growth Rate (2017-2022) 11.1.2 EU Nanomedicine Revenue and Growth Rate (2017-2022) 11.1.3 Japan Nanomedicine Revenue and Growth Rate (2017-2022) 11.1.4 China Nanomedicine Revenue and Growth Rate (2017-2022) 11.1.5 India Nanomedicine Revenue and Growth Rate (2017-2022) 11.1.6 Southeast Asia Nanomedicine Revenue and Growth Rate (2017-2022) 11.2 Global Nanomedicine Market Size (Value) by Type (2017-2022) 11.3 Global Nanomedicine Market Size by Application (2017-2022) 12 Nanomedicine Market Dynamics 12.1 Nanomedicine Market Opportunities 12.2 Nanomedicine Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Nanomedicine Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Nanomedicine Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Nanomedicine Product Scope Figure Global Nanomedicine Market Size (Million USD) (2012-2017) Table Global Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Nanomedicine Market Share by Regions in 2016 Figure United States Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure EU Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Japan Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure China Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure India Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Southeast Asia Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Nanomedicine Market Share by Type in 2016 Figure Regenerative Medicine Market Size (Million USD) and Growth Rate (2012-2017) Figure In-vitro & In-vivo Diagnostics Market Size (Million USD) and Growth Rate (2012-2017) Figure Vaccines Market Size (Million USD) and Growth Rate (2012-2017) Figure Drug Delivery Market Size (Million USD) and Growth Rate (2012-2017) Figure Global Nanomedicine Market Share by Application in 2016 Figure Nanomedicine Market Size (Million USD) and Growth Rate in Clinical Cardiology (2012-2017) Figure Nanomedicine Market Size (Million USD) and Growth Rate in Urology (2012-2017) Figure Nanomedicine Market Size (Million USD) and Growth Rate in Genetics (2012-2017) Figure Nanomedicine Market Size (Million USD) and Growth Rate in Orthopedics (2012-2017) Figure Nanomedicine Market Size (Million USD) and Growth Rate in Ophthalmology (2012-2017) Table Nanomedicine Market Size (Million USD) by Players (2016 and 2017) Figure Nanomedicine Market Size Share by Players in 2016 Figure Nanomedicine Market Size Share by Players in 2017 Table GE Healthcare Basic Information List Table Nanomedicine Business Revenue (Million USD) of GE Healthcare (2012-2017) Figure GE Healthcare Nanomedicine Business Revenue Market Share in 2016 Table Johnson & Johnson Basic Information List Table Nanomedicine Business Revenue (Million USD) of Johnson & Johnson (2012-2017) Figure Johnson & Johnson Nanomedicine Business Revenue Market Share in 2016 Table Mallinckrodt plc Basic Information List Table Nanomedicine Business Revenue (Million USD) of Mallinckrodt plc (2012-2017) Figure Mallinckrodt plc Nanomedicine Business Revenue Market Share in 2016 Table Merck & Co. Inc. Basic Information List Table Nanomedicine Business Revenue (Million USD) of Merck & Co. Inc. (2012-2017) Figure Merck & Co. Inc. Nanomedicine Business Revenue Market Share in 2016 Table Nanosphere Inc. Basic Information List Table Nanomedicine Business Revenue (Million USD) of Nanosphere Inc. (2012-2017) Figure Nanosphere Inc. Nanomedicine Business Revenue Market Share in 2016 Table Pfizer Inc. Basic Information List Table Nanomedicine Business Revenue (Million USD) of Pfizer Inc. (2012-2017) Figure Pfizer Inc. Nanomedicine Business Revenue Market Share in 2016 Table Sigma-Tau Pharmaceuticals Inc. Basic Information List Table Nanomedicine Business Revenue (Million USD) of Sigma-Tau Pharmaceuticals Inc. (2012-2017) Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Business Revenue Market Share in 2016 Table Smith & Nephew PLC Basic Information List Table Nanomedicine Business Revenue (Million USD) of Smith & Nephew PLC (2012-2017) Figure Smith & Nephew PLC Nanomedicine Business Revenue Market Share in 2016 Table Stryker Corp Basic Information List Table Nanomedicine Business Revenue (Million USD) of Stryker Corp (2012-2017) Figure Stryker Corp Nanomedicine Business Revenue Market Share in 2016 Table Teva Pharmaceutical Industries Ltd. Basic Information List Table Nanomedicine Business Revenue (Million USD) of Teva Pharmaceutical Industries Ltd. (2012-2017) Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Business Revenue Market Share in 2016 Table UCB (Union chimique belge) S.A Basic Information List Table Nanomedicine Business Revenue (Million USD) of UCB (Union chimique belge) S.A (2012-2017) Figure UCB (Union chimique belge) S.A Nanomedicine Business Revenue Market Share in 2016 Table Global Nanomedicine Market Size (Million USD) by Type (2012-2017) Figure Global Nanomedicine Market Size Share by Type in 2012 Figure Global Nanomedicine Market Size Share by Type in 2013 Figure Global Nanomedicine Market Size Share by Type in 2014 Figure Global Nanomedicine Market Size Share by Type in 2015 Figure Global Nanomedicine Market Size Share by Type in 2016 Figure Global Nanomedicine Market Size Share by Type in 2017 Table Global Nanomedicine Market Size (Million USD) by Application (2012-2017) Figure Global Nanomedicine Market Size (Million USD) by Application in 2012 Figure Global Nanomedicine Market Size (Million USD) by Application in 2013 Figure Global Nanomedicine Market Size (Million USD) by Application in 2014 Figure Global Nanomedicine Market Size (Million USD) by Application in 2015 Figure Global Nanomedicine Market Size (Million USD) by Application in 2016 Figure Global Nanomedicine Market Size (Million USD) by Application in 2017 Table Top Consumer/End Users of Nanomedicine Figure United States Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table United States Nanomedicine Market Size (Million USD) by Players (2012-2017) Figure United States Nanomedicine Market Size Share by Players in 2016 Figure United States Nanomedicine Market Size Share by Players in 2017 Figure EU Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table EU Nanomedicine Market Size (Million USD) by Players (2012-2017) Figure EU Nanomedicine Market Size Share by Players in 2016 Figure EU Nanomedicine Market Size Share by Players in 2017 Figure Japan Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Japan Nanomedicine Market Size (Million USD) by Players (2012-2017) Figure Japan Nanomedicine Market Size Share by Players in 2016 Figure Japan Nanomedicine Market Size Share by Players in 2017 Figure China Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table China Nanomedicine Market Size (Million USD) by Players (2012-2017) Figure China Nanomedicine Market Size Share by Players in 2016 Figure China Nanomedicine Market Size Share by Players in 2017 Figure India Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table India Nanomedicine Market Size (Million USD) by Players (2012-2017) Figure India Nanomedicine Market Size Share by Players in 2016 Figure India Nanomedicine Market Size Share by Players in 2017 Figure Southeast Asia Nanomedicine Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Southeast Asia Nanomedicine Market Size (Million USD) by Players (2012-2017) Figure Southeast Asia Nanomedicine Market Size Share by Players in 2016 Figure Southeast Asia Nanomedicine Market Size Share by Players in 2017 Figure Global Nanomedicine Market Size (Million USD) by Regions (2017-2022) Table Global Nanomedicine Market Size (Million USD) by Regions (2017-2022) Figure Global Nanomedicine Market Size Share by Regions in 2017 Figure Global Nanomedicine Market Size Share by Regions in 2022 Figure United States Nanomedicine Revenue (Million USD) and Growth Rate (2017-2022) Figure EU Nanomedicine Revenue (Million USD) and Growth Rate (2017-2022) Figure Japan Nanomedicine Revenue (Million USD) and Growth Rate (2017-2022) Figure China Nanomedicine Revenue (Million USD) and Growth Rate (2017-2022) Figure India Nanomedicine Revenue (Million USD) and Growth Rate (2017-2022) Figure Southeast Asia Nanomedicine Revenue (Million USD) and Growth Rate (2017-2022) Table Global Nanomedicine Market Size (Million USD) by Type (2017-2022) Figure Global Nanomedicine Market Size Share by Type in 2017 Figure Global Nanomedicine Market Size Share by Type in 2022 Table Global Nanomedicine Market Size (Million USD) by Application (2017-2022) Figure Global Nanomedicine Market Size (Million USD) by Application in 2017 Figure Global Nanomedicine Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.